Clinical Trial Update: Pharmacokinetic Characterization of Intramuscular Olanzapine Depot [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update characterizing the pharmacokinetics of intramuscular olanzapine depot (olanzapine pamoate) in schizophrenia and schizoaffective di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Relprevv (olanzapine pamoate)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 1 | Status: COMPLETED